3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
11
Breast
3
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
19
Colonic Neoplasms
16
Rectal Neoplasms
15
Pancreatic Neoplasms
12
Liver Neoplasms
7
Esophageal Neoplasms
7
Stomach Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Carcinoma, Hepatocellular
5
Adenocarcinoma Of Esophagus
5
Gallbladder Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Small Cell Lung Carcinoma
2
Salivary Gland Neoplasms
2
Precancerous Conditions
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Wilms Tumor
1
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Interventions
pembrolizumab
10
Paclitaxel
8
Taxes
6
Nivolumab
4
Cyclophosphamide
4
Cisplatin
4
Carboplatin
4
Polymerase Chain Reaction
3
Irinotecan
3
Interleukin-12 Subunit p35
3
Docetaxel
3
Bevacizumab
3
sargramostim
2
lenvatinib
2
aldesleukin
2
aflibercept
2
Trastuzumab
2
SS1(dsFv)PE38
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Methods
2
Interleukin-12
2
Gene Expression Profiling
2
Gemcitabine
2
Filgrastim
2
Early Intervention, Educational
2
Capecitabine
2
Albumin-Bound Paclitaxel
2
veliparib
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Immunohistochemistry
×
Gastrointestinal
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled